Slide 1: Q1 2026 Results Presentation
• Q1 2026 RESULTS PRESENTATION • May 14th, 2026
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary Q1 2026 key trends and figures Q1 2026 Sales at €105m, +3.9% organic growth vs. Q1 2025 €25.9m adjusted EBITDA in Q1 2026, +0.3% YoY, with 24.
Slide 3: Q1 2026 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2026 Results At-a-Glance Solid organic revenue growth and EBITDA % expansion SALES Adjusted EBITDA and % Net Financial Position and Leverage €m €m €m Excl. F
Slide 4: Sales – Q1 2026 vs. Q1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – Q1 2026 vs. Q1 2025 +3.9% YoY organic growth, supported by volume and pricing SALES – Q1 2025 TO Q1 2026 BRIDGE €m 107.2 • +3.9% growth excl. FX vs. Q1
Slide 5: Sales – Q1 2026 Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – Q1 2026 Performance by Division Healthcare organic sales growing across all the three subdivisions Healthcare & Life Sciences Safety Energy & Mobility €
Slide 6: Adj. EBITDA – Q1 2026 vs. Q1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. EBITDA – Q1 2026 vs. Q1 2025 57 bps of margin expansion, supported by pricing ADJ. EBITDA – Q1 2025 TO Q1 2026 BRIDGE €m 24.1% ADJUSTED EBITDA % 24.6% 57bp
Slide 7: Adj. Net Income – Q1 2026 vs. Q1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. Net Income – Q1 2026 vs. Q1 2025 10.2% margin excl. FX impact Adj. Net Income Adj. Net Income Excl. FX Gains/Losses €m €m 14.1 12.0 -10.7% 10.7 13.4% 5.7 1
Slide 8: Net Financial Position – Q1 2026 vs. FY 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Net Financial Position – Q1 2026 vs. FY 2025 Quarterly NFP increase mostly linked to NWC seasonality NET FINANCIAL POSITION – FY 2025 TO Q1 2026 BRIDGE €m 2.5x
Slide 9: FY 2026 – Strategic Focus and Guidance Confirmed
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx FY 2026 – Strategic Focus and Guidance Confirmed Focus on organic growth post M&A integration • MedTech: Establish new subdivisions to sharpen commercial focus
Slide 10: Partial Tender Offer on Treasury Shares
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Partial Tender Offer on Treasury Shares Buyback offer for up to 23.3M shares - ~12.3% of share capital • Voluntary partial tender offer on treasury shares: on 1
Slide 11: Q1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2026 Results – Financial Statements Q1 2025 and Q1 2026 P&L – Statutory Adjusted View of which Q1 2025 of which Q1 2026 €m Q1 2025 % Q1 2026 % non-recurring
Slide 12: Q1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2026 Results – Financial Statements Reclassified Balance Sheet - FY 2025 – Q1 2026 As of As of €m 31-Dec-2025 31-Mar-2026 Net intangible fixed assets 434.3 4
Slide 13: Q1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2026 Results – Financial Statements Cash Flow Statement – Q1 2025 – Q1 2026 €m Q1 2025 Q1 2026 Pre-tax result 2.5 15.4 Amortisation, depreciation and writedo
Slide 14: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate